01620nam 2200457 450 991070723750332120160622102658.0(CKB)5470000002463134(OCoLC)952027484(OCoLC)995470000002463134(EXLCZ)99547000000246313420160622d2006 ua 0engurmn|||||||||rdacontentrdamediardacarrierMedicare reimbursement for new end stage renal disease drugs[Washington, D.C.] :Department of Health and Human Services, Office of Inspector General,2006.1 online resource (iii, 8 pages)Title from title screen (viewed June 21, 2016)."March 2006.""OEI-03-06-00200."Includes bibliographical references.Medicare reimbursement for new ESRD disease drugsMedicareClaims administrationChronic renal failureTreatmentUnited StatesFinanceDrugsUnited StatesCostsPharmaceutical services insuranceUnited StatesPharmaceutical policyUnited StatesMedicareClaims administration.Chronic renal failureTreatmentFinance.DrugsCosts.Pharmaceutical services insurancePharmaceutical policyGPOGPOBOOK9910707237503321Medicare reimbursement for new end stage renal disease drugs3310690UNINA